EMA/PE/0000223677 - paediatric investigation plan
coramitug
PIPHuman
French is available via eTranslation, the European Commission's machine translation service.
Translate to French | Important information about machine translation
Key facts
- Active substance
- coramitug
- Therapeutic area
- Immune system disorders
- Decision number
- EMA/PE/0000223677
- PIP number
- EMA/PE/0000223677
- Pharmaceutical form(s)
- Powder for solution for infusion
- Condition(s) / indication(s)
- Adjunctive treatment in haematopoietic cell transplantation
- Treatment of transthyretin amyloidosis (ATTR)
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Novo Nordisk A/S
E-mail: paediatrics@novonordisk.com
Tel.: +45 44448888- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date
- Compliance check done
- Non